Lithium Low-Dose
Research Papers and Clinical Trials
The research on low-dose lithium spans several therapeutic areas, with notable studies examining its potential in dementia prevention and psychiatric applications.
Dementia and Cognitive Outcomes
A major 2026 propensity-matched cohort study published in Psychiatry Research compared low-dose lithium to valproate for preventing incident dementia diagnoses in older adults using electronic health record data. This observational study design helps control for confounding factors when comparing treatment outcomes in real-world settings.
Two additional 2026 reviews provide broader context: a narrative review in JAMA Psychiatry traced lithium's 25-year evolution as a potential disease-modifying agent for dementia, while a systematic review in CNS Spectrums examined lithium's long-term cognitive effects in both bipolar disorder and early dementia patients.
Clinical Trial Evidence
Several completed clinical trials have investigated low-dose lithium across different conditions:
- A Phase 4 trial (NCT00202306) studied low-dose lithium for indicated prevention of psychotic disorders
- A Phase 2 study (NCT02862210) examined low-dose lithium for behavioral symptoms in frontotemporal dementia
- Another Phase 2 trial (NCT00501540) investigated lithium for low-grade neuroendocrine tumors
- A Phase 2 Alzheimer's disease trial (NCT01055392) explored lithium's disease-modifying properties, though its current status is unknown
Other Research Areas
The evidence base also includes case reports, such as a 2026 Cureus publication documenting 15-month hematological stability during clozapine rechallenge with adjunctive lithium. Several studies in the search results appear unrelated to therapeutic lithium use, focusing instead on other compounds or applications.
Limitations
The available evidence shows active research interest in low-dose lithium, particularly for neurodegenerative conditions, but specific study designs, sample sizes, and detailed outcomes are not provided in these search results. More detailed study information would be needed to fully evaluate the strength of evidence for different applications.
Note: This information is for educational purposes only and should not replace professional medical advice. Consult healthcare providers for treatment decisions.
Free account required
Research papers requires a free AXIFI account to access clinical data, safety profiles, and research papers.